This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Paul Scolardi

Contributor

Paul Scolardi is the CEO of Super Trades LLC. He spent 16 years in corporate finance and is a Certified Public Accountant. Scolardi has also been investing/trading in stocks for more than 17 years.

 

Scolardi has also been featured on TheStreet.com, Bloomberg, BusinessWeek and Seeking Alpha. Scolardi currently works as a financial educator and trader.

Paul Scolardi
By This Author:
« Back
Page 1 of 2

10 Reasons You Should Not Make a Trade From What You Read on Twitter

By Paul Scolardi

Blindly following other people into trades can lead to painful losses.

12:48PM 02/11/15

CyberArk Software Could Be a Good Buy Ahead of Earnings

By Paul Scolardi

Cybersecurity is a hot industry right now, and a new player might be a good investment ahead of earnings next week.

12:59PM 02/04/15

Feasting on Cheeseburger Trades: How Buying Shake Shack and Habit Burger Paid Off

By Paul Scolardi

A lesson in 'sympathy' trading. That is, buying a stock that is similar to one that is moving strongly.

01:49PM 02/02/15

So Far in 2015, This Choppy Market Is for Stock-Picker's Only

By Paul Scolardi

With no clear direction in the market, picking individual stocks has been key to making money in 2015.

01:55PM 01/28/15

Flexible Solutions International Could Be a Good Buy If Droughts Persist

By Paul Scolardi

With many parts of the world battling drought, this penny stock might be one to take a closer look at.

11:24AM 01/23/15

Please Stop Trying To Be A Hero By Calling The Oil Bottom

By Paul Scolardi

It Is As Simple As High School Economics

01:40PM 01/09/15

How to Invest in the New Industry of 'Biosimilar' or 'Generic' Biological Drugs

By Paul Scolardi

With the FDA backing its first 'biosimilar' drug, it may be time to invest in this new area of growth for pharmaceuticals.

12:57PM 01/09/15

After CAR-T: Getting Ahead of the Next Hot Trend in Cancer Stocks

By Paul Scolardi

Here's how investors can help fund the next cure for cancer: anti-CD47 antibody therapies.

08:30AM 01/06/15

Hurco Is Working on a Potentially Disruptive 3D Printing Product

By Paul Scolardi

Move over 3D Systems and Stratasys. A 46-year-old Hurco has filed a U.S. patent for what may be disruptive technology that combines 3D printing with your basic CNC machine.

03:38PM 07/17/14

How to Get Stock Exposure to Gluten-Free Movement

By Paul Scolardi

Everywhere, there's talk of gluten-free diets. Here's an undervalued growth stock to get exposure to the trend.

06:30AM 05/21/14

« Back
Page 1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs